These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23317352)

  • 41. Does a growing tumour volume induce lymphangiogenesis? A study of oral/oropharyngeal cancer.
    Chung EJ; Rho YS; Baek SK; Woo JS; Kwon SY; Lee NJ; Chae YS; Jung KY
    J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):311-7. PubMed ID: 21777549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer.
    Liu J; Liu C; Qiu L; Li J; Zhang P; Sun Y
    Diagn Pathol; 2014 Jun; 9():128. PubMed ID: 24972450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
    Li X; Liu B; Xiao J; Yuan Y; Ma J; Zhang Y
    J Gastrointest Surg; 2011 Nov; 15(11):2001-10. PubMed ID: 21786062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma.
    Su C; Chen Z; Luo H; Su Y; Liu W; Cai L; Wang T; Lei Y; Zhong B
    J Exp Clin Cancer Res; 2011 Sep; 30(1):85. PubMed ID: 21939555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
    Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
    J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer.
    Lv XH; Liu BQ; Li XM; Wang XC; Li XL; Ahmed N; Zhang YF
    Anat Rec (Hoboken); 2016 Jun; 299(6):741-7. PubMed ID: 26917449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
    Yuanming L; Feng G; Lei T; Ying W
    Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry.
    Laerum OD; Ovrebo K; Skarstein A; Christensen IJ; Alpízar-Alpízar W; Helgeland L; Danø K; Nielsen BS; Illemann M
    Int J Cancer; 2012 Aug; 131(3):558-69. PubMed ID: 21866548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas.
    Zorgetto VA; Silveira GG; Oliveira-Costa JP; Soave DF; Soares FA; Ribeiro-Silva A
    Diagn Pathol; 2013 Oct; 8():170. PubMed ID: 24138811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
    Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of CD44v3, erythropoietin and VEGF-C in gastric adenocarcinomas: correlations with clinicopathological features.
    Wang L; Li HG; Wen JM; Peng TS; Zeng H; Wang LY
    Tumori; 2014; 100(3):321-7. PubMed ID: 25076245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
    Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
    Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
    World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A; Ersöz C; Karasoy D; Sak S
    Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
    Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
    Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.